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Abstract
Background: The prevalence of obesity is rising in Scotland and globally. Overall, obesity is associated with
increased morbidity, mortality and reduced health-related quality of life. Studies suggest that “healthy obesity”
(obesity without metabolic comorbidity) may not be associated with morbidity or mortality. Its impact on health-
related quality of life is unknown.
Methods: We extracted data from the Scottish Health Survey on self-reported health-related quality of life, body
mass index (BMI), demographic information and comorbidity. SF-12 responses were converted into an overall
health utility score. Linear regression analyses were used to explore the association between BMI and health utility,
stratified by the presence or absence of metabolic comorbidity (diabetes, hypertension, hypercholesterolemia or
cardiovascular disease), and adjusted for potential confounders (age, sex and deprivation quintile).
Results: Of the 5,608 individuals, 3,744 (66.8%) were either overweight or obese and 921 (16.4%) had metabolic
comorbidity. There was an inverted U-shaped relationship whereby health utility was highest among overweight
individuals and fell with increasing BMI. There was a significant interaction with metabolic comorbidity (p = 0.007).
Individuals with metabolic comorbidty had lower utility scores and a steeper decline in utility with increasing BMI
(morbidly obese, adjusted coefficient: -0.064, 95% CI -0.115, -0.012, p = 0.015 for metabolic comorbidity versus
-0.042, 95% CI -0.067, -0.018, p = 0.001 for no metabolic comorbidity).
Conclusions: The adverse impact of obesity on health-related quality of life is greater among individuals with
metabolic comorbidity. However, increased BMI is associated with reduced health-related quality of life even in the
absence of metabolic comorbidity, casting doubt on the notion of “healthy obesity”.
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Background
According to the World Health Organisation (WHO),
more than one in ten of the world’s adult population
are obese [1]. In Scotland, around two-thirds of adult
men and more than one-half of adult women are either
overweight or obese (http://www.scotland.gov.uk/
Topics/Statistics/Browse/Health/TrendObesity) and, in
common with other developed countries, the prevalence
is increasing. Overall, obesity is associated with an
increased risk of many conditions including hyperten-
sion, hypercholesterolemia, type II diabetes and cardio-
vascular disease [2-5]. It is also associated with reduced
life-expectancy [6-9]. There is growing evidence that the
association between obesity and fatal or non-fatal events
is mediated via these other conditions and that isolated
obesity may not be injurious to health. In the United
States of America, around 29% of obese men and 45%
of obese women (totalling 19.5 million individuals) do
not have metabolic comorbid conditions [10]. They do
not appear to be at increased risk of cardiovascular
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will not be beneficial and may even increase their risk of
cardio-metabolic outcomes [10-15]. This had led to the
term “healthy obesity.” Overall, obesity is associated
with anxiety, depression and impaired health-related
quality of life [16-19]. Previous research suggests that
d e t e r i o r a t i o ni nh e a l t h - r e lated quality of life in over-
weight and obese individuals may be due to the pre-
sence of comorbidity [20]. It is currently unknown
whether isolated or “healthy” obesity is associated with
the decline in health-related quality of life. In this study,
we used data from a Scotland-wide survey to address
this question by comparing the health-related quality of
life across the BMI category of people in the presence
and absence of metabolic comorbidity.
Methods
Data source
The Scottish Health Survey has been conducted at regu-
lar intervals, of 3-5 years, since 1995. The Survey uses
multi-stage, stratified probability sampling to ensure a
representative sample of the general population. The
trained staff collected data via face to face interview
(including age, sex, postcode of residence, lifestyle risk
factors, medication, past medical history and current
health) and measured weight, height and blood pressure
and obtained blood samples for assays (including total
cholesterol concentrations) (http://www.esds.ac.uk/gov-
ernment/shes/). We used an extract of data from the
2003 Survey, the focus of which was cardiovascular dis-
ease and risk factors.
Inclusion criteria and definitions
Our analyses were restricted to participants aged ≥ 20
years and those included were categorised into three age
groups: 20-44, 45-64 and ≥ 65 years. Postcode of resi-
dence was used to allocate individuals to a socioeco-
nomic quintile of the general population using the 2004
Scottish Index of Multiple Deprivation (SIMD) (http://
www.scotland.gov.uk/Publications/2005/01/20458/
49127). The index is derived from 31 markers of depriva-
tion relating to health, education, housing, current
income, employment access and crime, that are applied
to each postcode data zones. There are 6,505 data zones
in Scotland with a mean population of 750. Body Mass
Index (BMI) was categorised according to the World
Health Organisation definition [21]: underweight (BMI <
18.5 kg/m
2), normal weight (BMI 18.5-24.9 kg/m
2), over-
weight (BMI 25.0-29.9 40 kg/m
2), and obese (BMI 30.0-
39.9 kg/m
2), with the addition of a category for morbidly
obese (BMI ≥ 40 kg/m
2). Metabolic comorbidity was
defined as the presence of one or more of the following
conditions known to be associated with obesity: diabetes,
hypertension, hypercholesterolemia or cardiovascular
disease. Cardiovascular disease was defined as angina or
a past history of stroke or myocardial infarction and was
based on participants reporting diagnosis by a doctor.
Hypertension was defined as a blood pressure measure-
ment of ≥ 140/90 mmHg, or anti-hypertensive medica-
tion. Hypercholesterolaemia was defined as a total
cholesterol concentration ≥ 5.2 mmol/L, or lipid-lower-
ing medication. Smoking status was self-reported and
classified as never, ex- or current smoker. Alcohol con-
sumption was self-reported and categorised as never, ex-,
sensible and excessive, with the cut-off between sensible
and excessive drinking defined as more than 14 units/
week for women and 21 units/week for men [20] The
responses obtained from the SF-12 questionnaires were
converted into a single utility score using an algorithm
developed by Brazier and colleagues at the University of
Sheffield (http://www.shef.ac.uk/scharr/sections/heds/
mvh/sf-6d/revisions.html) [22].
Statistical analyses
All statistical analyses were performed using Stata version
11.2 (Stata Corporation, College Station, Texas, USA).
Categorical data were summarized using frequencies and
percentages and groups were compared using chi-square
tests, or chi-square tests for trend for ordinal data. We
used univariate and multivariate linear regression models
to examine the association between BMI category and
utility score, adjusting for the potential confounding
effects of age, sex, deprivation quintiles, smoking status
and alcohol consumption. Normal weight was used as
the referent category. We tested whether there was a sta-
tistically significant interaction with metabolic comorbid-
ity and stratified the analyses by the presence of
metabolic comorbidity. The robustness of standard errors
was checked using the bootstrapping method.
Results
Of the 10,470 individuals who participated in the Scottish
Health Survey, 7,097 were aged ≥ 20 years. Of these 6,559
(92%) had sufficient data to calculate a utility score. Parti-
cipants who completed the SF-12 instrument were not
significantly different in terms of BMI category (p =
0.225) and sex (p = 0.197), but were younger (p <0 . 0 0 1 ) ,
less socioeconomically deprived, (p <0 . 0 0 1 ) ,a n dm o r e
likely to have metabolic comorbidity (p < 0.001). Among
the 6,559 participants with a utility score, 5,608 (86%)
also had BMI recorded and they comprised the study
population. These individuals were not significantly dif-
ferent in term of metabolic comorbidity (p = 0.582) but
were younger (p < 0.001), more likely to be male (p <
0.001) and less socioeconomically deprived (p = 0.020).
Of the 5,608 individuals, 2,531 (45.1%) were men and
the mean age was 50 years (standard deviation 16
years). Nine hundred and twenty one (16.4%) had
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Page 2 of 7metabolic comorbidity and the mean utility score was
0.80 (standard deviation 0.14). One thousand seven hun-
dred and ninety seven (32.0%) were normal weight,
2,276 (40.6%) overweight, 1,319 (23.5%) obese, 149
(2.7%) morbidly obese, and 67 (1.2%) underweight.
There were significant differences between the BMI
categories in terms of age and sex (Table 1). The per-
centage belonging to the most deprived quintile
increased significantly from normal weight to morbidly
obese, as did the percentage with metabolic comorbidity
(Table 1).
In relation to the association between BMI category
and utility score, there was a significant interaction with
metabolic comorbidity (p = 0.007). In every BMI cate-
gory, the utility score was lower among those with
metabolic comorbidity (Figure 1). Among both indivi-
duals with and without metabolic comorbidity, there
was an inverted U-shaped relationship whereby health
utility was highest among overweight individuals and fell
with increasing BMI, with the decline steepest among
those with metabolic comorbidity (Figure 1). Health
related-quality of life was significantly reduced among
obese individuals regardless of the presence or absence
of metabolic comorbidity. After adjustment for the
potential confounding effects of age, sex, deprivation
smoking status and alcohol consumption, the utility
score was non-significantly higher among overweight
than normal weight individuals, irrespective of the pre-
sence of metabolic comorbidity (Table 2). Compared
with normal weight individuals, utility scores were sig-
nificantly lower among both morbidly obese and under-
weight individuals in both groups (Table 2).
Discussion
Individuals with metabolic comorbidity have a poorer
health-related quality of life than those without, irre-
spective of their BMI. However, health-related quality of
life is significantly reduced among obese individuals
even in the absence of metabolic comorbidity, suggest-
ing that “healthy obesity” is a misnomer. Our findings
are consistent with previous studies that have demon-
strated reduced health-related quality of life among
Table 1 Characteristics of participants by body mass index category
Underweight Normal weight Overweight Obese Morbidly obese
‡p-value Overall
N = 67 N = 1,797 N = 2,276 N = 1,319 N = 149 N = 5, 608
N (%) N (%) N (%) N (%) N (%) N (%)
Age (years)
20-44 32 (47.8) 937 (52.1) 858 (37.7) 440 (33.4) 54 (36.2) < 0.001 2,321 (41.4)
45-64 21 (31.3) 562 (31.3) 916 (40.3) 549 (41.6) 75 (50.3) 2,123 (37.9)
≥ 65 14 (20.9) 298 (16.6) 502 (22.1) 330 (25.0) 20 (13.4) 1, 164 (20.8)
Sex
Male 26 (38.8) 688 (38.3) 1,183 (52.0) 598 (45.3) 36 (24.2) < 0.001 2,531 (45.1)
Female 41 (61.2) 1,109 (61.7) 1,093 (48.0) 721 (54.7) 113 (75.8) 3,077 (54.9)
Deprivation quintile
1 (Least deprived) 14 (20.9) 389 (21.7) 498 (21.9) 218 (16.5) 16 (10.7) < 0.001 1,135 (20.2)
2 11 (16.4) 413 (23.0) 537 (23.6) 258 (19.6) 30 (20.1) 1,249 (22.3)
3 9 (13.4) 385 (21.4) 503 (22.1) 337 (25.6) 29 (19.5) 1,263 (22.5)
4 14 (20.9) 322 (17.9) 427 (18.8) 276 (20.9) 26 (17.6) 1,065 (19.0)
5 (Most deprived) 19 (28.4) 288 (16.0) 311 (13.7) 230 (17.4) 48 (32.2) 896 (16.0)
Metabolic comorbidity
No 59 (88.1) 1,632 (90.8) 1,899 (83.4) 990 (75.0) 107 (71.8) < 0.001 4,687 (83.6)
Yes 8 (12.0) 165 (9.2) 377 (16.6) 329 (25.0) 42 (28.2) 921 (16.4)
Smoking status
Never smoker 21 (31.3) 748 (41.6) 1, 002 (44.0) 599 (45.4) 60 (40.3) < 0.001 2, 430 (43.3)
Ex-smoker 7 (10.5) 409 (22.8) 737 (32.4) 447 (33.9) 56 (37.6) 1, 656 (29.5)
Current smoker 39 (58.2) 640 (35.6) 537 (23.6) 273 (20.7) 33 (22.2) 1, 522 (27.1)
Drinking status
Never drinker 12 (17.9) 89 (5.0) 106 (4.7) 72 (5.5) 8 (5.4) < 0.001 287 (5.1)
Ex-drinker 5 (7.5) 83 (4.6) 85 (3.7) 62 (4.7) 14 (9.4) 249 (4.4)
Sensible drinker* 39 (58.2) 1, 266 (70.5) 1, 560 (68.5) 936 (70.9) 100 (67.1) 3, 901 (69.5)
Excessive drinker 11 (16.4) 352 (19.7) 522 (23.0) 246 (18.7) 27 (18.1) 1, 158 (20.7)
Missing 0 (0) 7 (0.39) 3 (0.13) 3 (0.23) 0 (0) 13 (0.23)
‡chi-square tests for trend * < 21 units/week for men, < 14 units/week for women
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Page 3 of 7obese individuals [17,18,23-28]. However, these studies
have only considered obese individuals as a whole. His-
torically, normal weight was associated with the lowest
risk of cardiovascular diseases and type II diabetes, and
the highest health-related quality of life [17,29]. This has
changed over time, and our finding of non-significantly
higher health-related quality of life among overweight
individuals is consistent with other recent studies
[28,30-32]. Previous studies have also shown poorer
health among individuals with a low BMI [28,33,34].
This is likely to be due, in part, to reverse causation due
to conditions other than those that we included in our
definition of metabolic comorbidity.
There is a growing consensus that the increased risk of
cardiometabolic events associated with obesity is
mediated, largely, via the increased risk of intermediate
conditions such as hypertension, hypercholesterolemia
and type II diabetes [21]. A number of studies have identi-
fied a sub-group of obese individuals who do not develop
these intermediate conditions [11]. They are not at signifi-
cantly increased risk of cardiometabolic events, and weight
loss does not improve their natural history [10-15]. These
findings have led to the label “healthy” obesity.
Health extends beyond clinical events, to encompass
psychological well-being. A number of studies have
shown that health-related quality of life is reduced
among obese individuals [35-38]. It was not previously
known whether, as with clinical events, this risk was
specific to obese individuals with metabolic comorbidity.
Our study demonstrated that, whilst health-related qual-
ity of life was lower among individuals with metabolic
comorbidity, it was nonetheless significantly reduced
among obese individuals with no metabolic comorbidity.
The study used data from a large pan-Scotland survey
representative of the general population. Due to incom-
p l e t ed a t ao nB M Io ru t i l i t ys c o r ei n1 4 %o fp a r t i c i p a n t s ,
the study population was younger, more affluent and
healthier than the overall survey population. However,
this is unlikely to affect the generalisability of the results.
Access to information on metabolic comorbidity enabled
us to undertake sub-group analyses. BMI and blood pres-
sure measurements were made by trained fieldworkers
using standard operating procedures and the presence of
hypercholesterolemia was based on blood assays. Pre-
sence of diabetes and cardiovascular disease were based
on clinician diagnosis but reported by participants. Since
the study was conducted retrospectively, this is unlikely
to have led to reporting bias. In a cross-sectional study, a
temporal relationship cannot be established. Therefore,
reverse causation is possible. This is particularly so
among individuals who are below normal weight in
whom other conditions may be causing both poor
health-related quality of life and weight loss. Survival bias
may also occur in cross-sectional studies. Our findings
should be corroborated within the context of a cohort
study.
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Figure 1 Mean utility score by body mass index category and presence of metabolic comorbidity (unadjusted).
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Page 4 of 7Table 2 Linear regression analysis of the factors associated with utility score by presence or absence of metabolic comorbidity
Univariate Multivariate
No metabolic comorbidity With metabolic comorbidity No metabolic comorbidity With metabolic comorbidity
Coefficient (95% CI) P-value Coefficient (95% CI) P-value Coefficient (95% CI) P-value Coefficient (95% CI) P-value
BMI category Underweight -0.051 (-0.084, -0.018) 0.002 -0.167 (-0.275, -.059) 0.002 -0.036 (-0.069, -0.004) 0.027 -0.141 (-0.245, -0.037) 0.008
Normal-weight* - - - - - - - -
Overweight 0.008 (-0.000, 0.016) 0.059 0.032 (0.004, 0.060) 0.023 0.001 (-0.008, 0.009) 0.900 0.026 (-0.002, 0.053) 0.064
Obese -0.012 (-0.022, -0.002) 0.015 -0.012 (-0.041, 0.015) 0.380 -0.016 (-0.026, -0.006) 0.001 -0.015 (-0.043, 0.013) 0.290
Morbidly obese -0.054(-0.079, -0.029) < 0.001 -0.085 (-0.137, -0.034) 0.001 -0.045 (-0.069, -0.020) < 0.001 -0.077 (-0.128, -0.026) 0.003
Age (yrs) 20-44 0.002 (-0.005, 0.010) 0.500 0.001 (-0.036, 0.039) 0.924 0.005 (-0.002, 0.013) 0.190 0.007 (-0.030, 0.043) 0.714
45-64 - - - - - - - -
≥ 65 -0.007 (-0.018, 0.003) 0.191 0.004 (-0.016, 0.025) 0.663 -0.009 (-0.020, 0.002) 0.106 0.004 (-0.017, 0.024) 0.718
Sex M a l e * --------
Female -0.020 (-0.028, -0.013) < 0.001 -0.009 (-0.029, 0.010) 0.357 -0.020 (-0.027, -0.013) < 0. 001 -0.005 (-0.025, 0.015) 0.629
Deprivation quintiles
1(Least deprived)* - - - - - - - -
2 -0.012 (-0.023, -0.001) 0.030 -0.016(-0.048, 0.015) 0.313 -0.008 (-0.019, 0.002) 0.132 -0.009 (-0.040, 0.021) 0.546
3 -0.026 (-0.037, -0.015) < 0.001 -0.053(-0.085, -0.021) 0.001 -0.019 (-0.030, -0.008) 0.001 -0.036 (-0.068, -0.004) 0.027
4 -0.036 (-0.047, -0.024) < 0.001 -0.070(-0.103, -0.038) < 0.001 -0.026 (-0.038, -0.015) < 0.001 -0.050 (-0.082, -0.017) 0.003
5(Most deprived) -0.070 (-0.082, -0.058) < 0.001 -0.117(-0.150, -0.084) < 0.001 -0.052 (-0.064, -0.040) < 0.001 -0.084 (-0.117, -0.051) < 0.001
Smoking status Never smoker* - - - - - - - -
Ex-smoker -0.012 (-0.021, -0.004) 0.005 -0.031 (-0.053, -0.009) 0.006 -0.008 (-0.016, 0.001) 0.095 -0.031 (-0.053, -0.009) 0.006
Current smoker -0.051 (-0.060, -0.042) < 0.001 -0.085 (-0.113, -0.058) < 0.001 -0.041 (-0.050, -0.032) < 0.001 -0.067 (-0.095, -0.038) < 0.001
Drinking status Never drinker* - - - - - - - -
Ex-drinker -0.058 (-0.083, -0.033) < 0.001 -0.066 (-0.118, -0.013) 0.014 -0.050 (-0.075, -0.026) < 0.001 -0.043 (-0.094, 0.008) 0.098
Sensible drinker
‡ 0.010 (-0.008, 0.028) 0.281 0.033 (-0.002, 0.069) 0.067 0.003 (-0.014, 0.021) 0.710 0.032 (-0.02, 0.067) 0.068
Excessive drinker 0.005 (-0.014, 0.024) 0.623 0.056 (0.015, 0.097) 0.007 -0.001 (-0.020, 0.018) 0.925 0.052 (0.010, 0.093) 0.014
Missing -0.059 (-0.136, 0.018) 0.133 0.029 (-0.186, 0.244) 0.793 -0.054 (-0.130, 0.021) 0.156 0.033 (-0.173, 0.239) 0.754
*Referent category, CI confidence interval,
‡ < 21 units/week for men, < 14 units/week for women
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7Conclusions
Our study suggests that obesity is not only a risk for
fatal and non-fatal clinical events but also reduced
health-related quality of life, even in the absence of
comorbid conditions. Our findings cast doubt on the
notion of “healthy” obesity and reinforce the need for
population and individual interventions to reverse the
increasing prevalence of obesity.
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